Literature DB >> 20936827

Phosphoproteomics profiling suggests a role for nuclear βΙPKC in transcription processes of undifferentiated murine embryonic stem cells.

Helio Miranda Costa-Junior1, Nicole Milaré Garavello, Mariana Lemos Duarte, Denise Aparecida Berti, Talita Glaser, Alexander de Andrade, Carlos A Labate, André Teixeira da Silva Ferreira, Jonas Enrique Aguilar Perales, José Xavier-Neto, José Eduardo Krieger, Deborah Schechtman.   

Abstract

Protein kinase C (PKC) plays a key role in embryonic stem cell (ESC) proliferation, self-renewal, and differentiation. However, the function of specific PKC isoenzymes have yet to be determined. Of the PKCs expressed in undifferentiated ESCs, βIPKC was the only isoenzyme abundantly expressed in the nuclei. To investigate the role of βΙPKC in these cells, we employed a phosphoproteomics strategy and used two classical (cPKC) peptide modulators and one βIPKC-specific inhibitor peptide. We identified 13 nuclear proteins that are direct or indirect βΙPKC substrates in undifferentiated ESCs. These proteins are known to be involved in regulating transcription, splicing, and chromatin remodeling during proliferation and differentiation. Inhibiting βΙPKC had no effect on DNA synthesis in undifferentiated ESCs. However, upon differentiation, many cells seized to express βΙPKC and βΙPKC was frequently found in the cytoplasm. Taken together, our results suggest that βIPKC takes part in the processes that maintain ESCs in their undifferentiated state.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20936827     DOI: 10.1021/pr100355k

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  3 in total

1.  Identification of εPKC targets during cardiac ischemic injury.

Authors:  Grant Budas; Helio Miranda Costa; Julio Cesar Batista Ferreira; André Teixeira da Silva Ferreira; Jonas Perales; José Eduardo Krieger; Daria Mochly-Rosen; Deborah Schechtman
Journal:  Circ J       Date:  2012-03-27       Impact factor: 2.993

Review 2.  Protein kinase C in cancer: The top five unanswered questions.

Authors:  Mariana Cooke; Andrew Magimaidas; Victoria Casado-Medrano; Marcelo G Kazanietz
Journal:  Mol Carcinog       Date:  2017-03-10       Impact factor: 4.784

3.  Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC.

Authors:  Leona L Pott; Sascha Hagemann; Henning Reis; Kristina Lorenz; Thilo Bracht; Thomas Herold; Boris V Skryabin; Dominik A Megger; Julia Kälsch; Frank Weber; Barbara Sitek; Hideo A Baba
Journal:  Oncotarget       Date:  2017-02-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.